Arca
Skip to content
Tools
Tools

SIGMAR1: Sigma non-opioid intracellular receptor 1

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Functions in lipid transport from the endoplasmic reticulum and is involved in a wide array of cellular functions probably through regulation of the biogenesis of lipid microdomains at the plasma membrane.

  • Drugs that act on it: 4
  • Approved: 4
  • In phases 1 to 3: 0
  • Sponsors: 2

Who Is On It, and How Far Along

Every drug ChEMBL records acting on SIGMAR1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved4

  • Dextromethorphan
  • Fenfluramine
  • Carbetapentane
  • Pentazocine

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        Modalities

        Drugs on this target by ChEMBL molecule type.

        • Small molecule4100%

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DextromethorphanApprovedEli LillySmall moleculeAgonistSigma opioid receptor agonist22—
        FenfluramineApprovedUCBSmall moleculeAntagonistSigma opioid receptor antagonist8WithdrawnBoxed warning
        CarbetapentaneApproved—Small moleculeAgonistSigma opioid receptor agonist0Withdrawn
        PentazocineApproved—Small moleculeModulatorSigma opioid receptor modulator0Boxed warning

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
        A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).DextromethorphanPhase 1Not yet recruitingEli Lilly and Company2026-10-20
        A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult SubjectsDextromethorphanPhase 1RecruitingBasilea Pharmaceutica2026-10-19
        Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDDextromethorphanPhase 4Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh2026-10-06
        Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)DextromethorphanPhase 3RecruitingAxsome Therapeutics, Inc.2026-08-14
        A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsDextromethorphanPhase 1RecruitingEisai Inc.2026-08-14
        An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative ColitisDextromethorphanPhase 1RecruitingHoffmann-La Roche2026-06-24
        Using Fenfluramine to Test the Serotonin Deficiency Theory of DepressionFenfluramineNot applicableNot yet recruitingImperial College Healthcare NHS Trust2026-06-16
        Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive DisorderDextromethorphanPhase 1 / Phase 2RecruitingMclean Hospital2026-05-18
        Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)DextromethorphanPhase 2Not yet recruitingFirst Affiliated Hospital of Wenzhou Medical University2026-05-13
        EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine TreatmentFenfluramine—Enrolling by invitationUniversity of Chicago2026-04-29
        A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeFenfluraminePhase 3RecruitingUCB BIOSCIENCES, Inc.2026-03-31
        Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGSFenfluramineNot applicableEnrolling by invitationByteflies2025-11-06
        The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome ProjectFenfluraminePhase 4RecruitingThe University of Texas Health Science Center, Houston2025-08-08
        Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeFenfluraminePhase 4RecruitingUniversity of Colorado, Denver2024-09-19
        A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.FenfluraminePhase 3Active, not recruitingZogenix, Inc.2021-10-01
        Treatment of Refractory Infantile Spasms With FenfluramineFenfluraminePhase 2RecruitingChildren's Hospital of Orange County2020-02-28

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Autosomal recessive distal spinal muscular atrophy 2
        0.70
        Juvenile amyotrophic lateral sclerosis
        0.68
        Cough
        0.60
        Nasal congestion
        0.60
        Fever
        0.60
        Pain
        0.58

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL287, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q99720, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.